订阅小程序
旧版功能

Long-Term Follow-Up of Third Generation Anti-CD30 CAR T-Cell Bridging Autologous HSCT Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicentre, Phase 1-2 Trial

Xiangmin Wang,Qing Zhang,Xicheng Chen, Hongzhi Geng,Yaxue Jiao, Peiling Zhang, Yujie Li,Ruiyang Xie, Yawen Wei,Ziyuan Shen,Hongyuan Zhou, Tianci Li,Jiaoli Zhang,Dongmei Yan, Zhenyu Li,Yicheng Zhang,Tongcun Zhang, Caixia Li,Liang Huang,Kailin Xu,Wei Sang

crossref（2024）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要